• Advances in Management for Preterm Fetuses at Risk of Delivery
• Antenatal factors modulate hearing screen failure risk in preterm infants
• Drug therapy during pregnancy
• Effect of obesity on neonatal outcomes in pregnancies with preterm premature rupture of membranes
• Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus
• Etiology and outcome of fetuses with functional heart disease
• Evaluation of the Risk Factors for Acute Kidney Injury in Neonates Exposed to Antenatal Indomethacin
• Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age
• Hyperprostaglandin E syndrome: use of indomethacin and steroid, and death due to necrotizing enterocolitis and sepsis
• Mortality and morbidity in very low birth weight infants in the Basque Country and Navarra (2001-2006): population-based study
• Neonatal complications after the administration of indomethacin for preterm labor
• Patent arterial duct
• Perinatal indomethacin treatment and neonatal complications in preterm infants
• Prophylactic Interventions in Neonatology: How Do They Fare in Real Life?
• SMFM Consult Series #46: Evaluation and management of polyhydramnios
• Tocolysis with indomethacin increases the incidence of necrotizing enterocolitis in the low-birth-weight neonate
• Understanding clinical literature relevant to spontaneous intestinal perforations